INDEGENE
Back to Balance Sheet
|
INDEGENE Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | - | ₹403 Cr | ₹394 Cr | ₹18 Cr | ₹25 Cr |
What is the latest Total Debt ratio of INDEGENE ?
| Year | Total Debt |
|---|---|
| Mar2025 | - |
| Mar2024 | ₹403 Cr |
| Mar2023 | ₹394 Cr |
| Mar2022 | ₹18 Cr |
| Mar2021 | ₹25 Cr |
How is Total Debt of INDEGENE Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | - | -100.00 | |
| Mar2024 | ₹403 Cr | 2.23 | |
| Mar2023 | ₹394 Cr | 2,061.97 | |
| Mar2022 | ₹18 Cr | -26.35 | |
| Mar2021 | ₹25 Cr | - | |
Compare Total Debt of peers of INDEGENE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDEGENE | ₹12,615.8 Cr | -0.8% | 3.3% | -12.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,753.0 Cr | -0.2% | 1.1% | -0.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,205.0 Cr | 0.7% | -2.9% | 6.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹127,169.0 Cr | -0.9% | -1.6% | 13.6% | Stock Analytics | |
| CIPLA | ₹121,166.0 Cr | 0.7% | -2.4% | 4.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,749.0 Cr | 2.2% | 2.8% | 2.8% | Stock Analytics | |
INDEGENE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDEGENE | -0.8% |
3.3% |
-12.1% |
| SENSEX | 0% |
0.1% |
3.9% |
You may also like the below Video Courses